Related references
Note: Only part of the references are listed.Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2009)
Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease
Akira Andoh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2006)
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: A randomized, double-blind, placebo-controlled trial
P Rutgeerts et al.
GASTROENTEROLOGY (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
SB Hanauer et al.
GASTROENTEROLOGY (2004)
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
S Ardizzone et al.
GASTROENTEROLOGY (2004)
Guidelines for the management of inflammatory bowel disease in adults
MJ Carter et al.
GUT (2004)
Long-term Treatment of Rectovaginal Fistulas in Crohn's Disease: Response to Infliximab in the ACCENT II Study
Bruce E. Sands et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis
T Hibi et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)